OpenVSafe by OpenVAERS
Search V-safe

CK8-24614-29107

2 vaccinations 8 coded responses 21 check-ins 8 free-text entries 0 call cases
Sex
Female
Age at first dose
61-65
ZIP prefix
773 / TX
Registered
2021-02-20
Relationship
Self
Race
White
Ethnicity
Not Hispanic or Latino

Timeline

  1. 2021-02-20
    Registered in v-safe
  2. 2021-02-20
    Dose 1 — Pfizer-BioNTech
  3. 2021-02-20
    Survey response — day 0, dose 1
    MedDRA: Headache — Feeling: Good · Headache
    Free text: Slight headache, minimized by eating and hydrating afterward
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  4. 2021-02-21
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  5. 2021-02-26
    Survey response — days 1–6 daily, dose 1
    MedDRA: Abdominal pain upper, Blood pressure increased, Decreased appetite, Fatigue, Headache, Nausea, Vertigo positional — Feeling: Fair · Headache, Fatigue or tiredness, Abdominal pain · Be unable to do your normal daily activities
    Free text: Yesterday (2/25/21) awoke with severe positional vertigo, accompanying nausea, elevated BP, headache, tiredness, low appetite and later epigastric pain. This has continued.
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  6. 2021-02-27
    Survey response — day 7, dose 1
    MedDRA: Dizziness, Fatigue — Feeling: Fair · Headache, Fatigue or tiredness · Be unable to do your normal daily activities
    Free text: Condition improved since yesterday. No vertigo as such, just lightheaded. Only slight headache and occ. queasiness. Fatigue is the principal symptom
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  7. 2021-03-06
    Health check-in — day 14, dose 1
    Feeling: Good
    Adult check-in
  8. 2021-03-13
    Dose 2 — Pfizer-BioNTech
  9. 2021-03-13
    Health check-in — day 0, dose 2
    Feeling: Good · None
    Adult check-in
  10. 2021-03-14
    Health check-in — days 1–6 daily, dose 2
    Feeling: Poor · Site: Swelling · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activities
    Adult check-in
  11. 2021-03-15
    Survey response — days 1–6 daily, dose 2
    MedDRA: Asthenia, Decreased appetite, Nausea — Feeling: Fair · Site: Itching · Fever · Headache, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activities
    Free text: Low appetite, queasy, weakness
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  12. 2021-03-16
    Survey response — days 1–6 daily, dose 2
    MedDRA: Abdominal discomfort, Decreased appetite, Injection site discomfort, Injection site pain — Feeling: Fair · Site: Itching · Headache, Fatigue or tiredness · Be unable to do your normal daily activities
    Free text: Decreased appetite; GI sensitivity. Tenderness, discomfort at injection site
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  13. 2021-03-17
    Survey response — days 1–6 daily, dose 2
    MedDRA: Decreased appetite, Gastrointestinal disorder — Feeling: Fair · Site: Itching · Fatigue or tiredness · Be unable to do your normal daily activities
    Free text: Decreased appetite, GI sensitivity
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  14. 2021-03-18
    Survey response — days 1–6 daily, dose 2
    MedDRA: Dizziness, Injection site pain — Feeling: Fair · Fatigue or tiredness · Be unable to do your normal daily activities
    Free text: Lingering slight soreness at site; slightly lightheaded
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  15. 2021-03-19
    Health check-in — days 1–6 daily, dose 2
    Feeling: Fair · Fatigue or tiredness · Be unable to do your normal daily activities
    Adult check-in
  16. 2021-03-20
    Survey response — day 7, dose 2
    MedDRA: Fatigue — Feeling: Good · Fatigue or tiredness
    Free text: A little tired - not up to my usual energy level but better than yesterday
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  17. 2021-03-29
    Health check-in — day 14, dose 2
    Feeling: Good
    Adult check-in
  18. 2021-04-03
    Health check-in — day 21, dose 2
    Feeling: Good
    Adult check-in
  19. 2021-04-10
    Health check-in — day 28, dose 2
    Feeling: Good
    Adult check-in
  20. 2021-04-17
    Health check-in — day 35, dose 2
    Feeling: Good
    Adult check-in
  21. 2021-04-24
    Health check-in — day 42, dose 2
    Feeling: Good
    Adult check-in
  22. 2021-06-14
    Health check-in — 3 months, dose 2
    Feeling: Good
    Adult check-in
  23. 2021-09-11
    Health check-in — 6 months, dose 2
    Feeling: Good
    Adult check-in
  24. 2022-03-13
    Health check-in — 12 months, dose 2
    Feeling: Good
    Adult check-in

Vaccinations

DoseDateManufacturerCo-administered
12021-02-20Pfizer-BioNTech
22021-03-13Pfizer-BioNTech

Free text

Release 4 — day 0, dose 1

2021-02-20

Systemic reaction (other): Slight headache, minimized by eating and hydrating afterward

Release 4 — days 1–6 daily, dose 1

2021-02-26

Systemic reaction (other): Yesterday (2/25/21) awoke with severe positional vertigo, accompanying nausea, elevated BP, headache, tiredness, low appetite and later epigastric pain. This has continued.

Release 4 — day 7, dose 1

2021-02-27

Systemic reaction (other): Condition improved since yesterday. No vertigo as such, just lightheaded. Only slight headache and occ. queasiness. Fatigue is the principal symptom

Release 5 — days 1–6 daily, dose 2

2021-03-15

Systemic reaction (other): Low appetite, queasy, weakness

2021-03-16

Systemic reaction (other): Decreased appetite; GI sensitivity. Tenderness, discomfort at injection site

2021-03-17

Systemic reaction (other): Decreased appetite, GI sensitivity

2021-03-18

Systemic reaction (other): Lingering slight soreness at site; slightly lightheaded

Release 6 — day 7, dose 2

2021-03-20

Systemic reaction (other): A little tired - not up to my usual energy level but better than yesterday

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
SROAbdominal discomfort ✓ ✓ ✓
SROAbdominal pain upper ✓ ✓ ✓
SROAsthenia ✓ ✓ ✓
SROBlood pressure increased ✓ ✓ ✓
SRODecreased appetite ✓ ✓ ✓
SRODizziness ✓ ✓ ✓
SROFatigue ✓ ✓ ✓
SROGastrointestinal disorder ✓ ✓ ✓
SROHeadache ✓ ✓ ✓
SROInjection site discomfort ✓ ✓ ✓
SROInjection site pain ✓ ✓ ✓
SRONausea ✓ ✓ ✓
SROVertigo positional ✓ ✓ ✓

✓ active code · ○ coded but marked inactive · blank = not in that release